APA

Dooren M. C., Kuijpers R. W., Joekes E. C., Huiskes E., Goldschmeding R., Overbeeke M. A., von dem Borne A. E., Engelfriet C. P. & Ouwehand W. H. (19920528). Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). : Lancet (London, England).

Chicago

Dooren M C, Kuijpers R W, Joekes E C, Huiskes E, Goldschmeding R, Overbeeke M A, von dem Borne A E, Engelfriet C P and Ouwehand W H. 19920528. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). : Lancet (London, England).

Harvard

Dooren M. C., Kuijpers R. W., Joekes E. C., Huiskes E., Goldschmeding R., Overbeeke M. A., von dem Borne A. E., Engelfriet C. P. and Ouwehand W. H. (19920528). Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). : Lancet (London, England).

MLA

Dooren M C, Kuijpers R W, Joekes E C, Huiskes E, Goldschmeding R, Overbeeke M A, von dem Borne A E, Engelfriet C P and Ouwehand W H. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). : Lancet (London, England). 19920528.